TD Cowen Upgrades Moderna (MRNA) to Outperform, 'The Risk/Reward And The Catalyst Path Ahead Is Favorable'

Go back to TD Cowen Upgrades Moderna (MRNA) to Outperform, 'The Risk/Reward And The Catalyst Path Ahead Is Favorable'

Moderna Outlines Commitment to Corporate Growth and Announces U.S. Expansion in 2023

March 10, 2023 11:01 AM EST

Expansion includes new West Coast offices in South San Francisco, California and Seattle, Washington

New offices complement existing locations in Cambridge, MA; Norwood, MA; Atlanta, GA; Bethesda, MD; and Princeton, NJ

Moderna currently has offices in 17 locations worldwide

Company plans to hire approximately 2,000 new employees in 2023

CAMBRIDGE, MA / ACCESSWIRE / March 10, 2023 / Moderna, Inc., (NASDAQ: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it is expanding its U.S. presence and establishing a... More